| Dr Christopher J Mann, MD | |
|
605 Pointe North Blvd, Albany, GA 31721-1514 | |
| (229) 435-7161 | |
| (229) 438-8588 |
| Full Name | Dr Christopher J Mann |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 37 Years |
| Location | 605 Pointe North Blvd, Albany, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346231594 | NPI | - | NPPES |
| 000502455A | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 031285 (Georgia) | Primary |
| 207K00000X | Allergy & Immunology | 031285 (Georgia) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Phoebe Putney Memorial Hospital | Albany, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Albany Ear Nose Throat Sinus And Allergy Llc | 1951367721 | 4 |
News Archive
Meda announced today positive results from a Phase III clinical trial of Dymista, a novel formulation of azelastine hydrochloride and fluticasone propionate, in patients with seasonal allergic rhinitis.
Scientists from the United States has recently evaluated the safety and efficacy profiles of ultraviolet-A (UVA) light applied via an endotracheal tube to critically ill COVID-19 patients.
Anton Paar now launches a new LED light source. A new integrated air pump makes cleaning and drying sample cells a lot more convenient...
Dermatologists agree that incidences of black henna reactions are on the rise. Out of the 288 dermatologists who took part in the recent Skin Health Alliance 2017 Dermatologist Survey, 72% thought the incidence of patients with a reaction to black henna temporary tattoos is increasing year on year.
Teva Pharmaceutical Industries Ltd., has presented results from a post hoc analysis of two pivotal Phase III clinical trials showing that treatment with reslizumab reduced clinical asthma exacerbations (CAEs) by 75 percent versus placebo in a subgroup of patients with late onset asthma (diagnosed at 40 years of age and older) with elevated blood eosinophils, who were inadequately controlled on inhaled corticosteroids (ICS).
› Verified 8 days ago
| Entity Name | Albany Ear Nose Throat Sinus & Allergy Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447309521 PECOS PAC ID: 1951367721 Enrollment ID: O20041203000087 |
News Archive
Meda announced today positive results from a Phase III clinical trial of Dymista, a novel formulation of azelastine hydrochloride and fluticasone propionate, in patients with seasonal allergic rhinitis.
Scientists from the United States has recently evaluated the safety and efficacy profiles of ultraviolet-A (UVA) light applied via an endotracheal tube to critically ill COVID-19 patients.
Anton Paar now launches a new LED light source. A new integrated air pump makes cleaning and drying sample cells a lot more convenient...
Dermatologists agree that incidences of black henna reactions are on the rise. Out of the 288 dermatologists who took part in the recent Skin Health Alliance 2017 Dermatologist Survey, 72% thought the incidence of patients with a reaction to black henna temporary tattoos is increasing year on year.
Teva Pharmaceutical Industries Ltd., has presented results from a post hoc analysis of two pivotal Phase III clinical trials showing that treatment with reslizumab reduced clinical asthma exacerbations (CAEs) by 75 percent versus placebo in a subgroup of patients with late onset asthma (diagnosed at 40 years of age and older) with elevated blood eosinophils, who were inadequately controlled on inhaled corticosteroids (ICS).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christopher J Mann, MD 605 Pointe North Blvd, Albany, GA 31721-1514 Ph: (229) 435-7161 | Dr Christopher J Mann, MD 605 Pointe North Blvd, Albany, GA 31721-1514 Ph: (229) 435-7161 |
News Archive
Meda announced today positive results from a Phase III clinical trial of Dymista, a novel formulation of azelastine hydrochloride and fluticasone propionate, in patients with seasonal allergic rhinitis.
Scientists from the United States has recently evaluated the safety and efficacy profiles of ultraviolet-A (UVA) light applied via an endotracheal tube to critically ill COVID-19 patients.
Anton Paar now launches a new LED light source. A new integrated air pump makes cleaning and drying sample cells a lot more convenient...
Dermatologists agree that incidences of black henna reactions are on the rise. Out of the 288 dermatologists who took part in the recent Skin Health Alliance 2017 Dermatologist Survey, 72% thought the incidence of patients with a reaction to black henna temporary tattoos is increasing year on year.
Teva Pharmaceutical Industries Ltd., has presented results from a post hoc analysis of two pivotal Phase III clinical trials showing that treatment with reslizumab reduced clinical asthma exacerbations (CAEs) by 75 percent versus placebo in a subgroup of patients with late onset asthma (diagnosed at 40 years of age and older) with elevated blood eosinophils, who were inadequately controlled on inhaled corticosteroids (ICS).
› Verified 8 days ago
Dr. John R Grant, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 605 Pointe North Blvd, Albany, GA 31721 Phone: 229-435-7161 Fax: 229-438-8588 | |
Dr. Magalie Nelson, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 605 Pointe North Blvd, Albany, GA 31721 Phone: 229-435-7161 Fax: 229-438-8588 |